Doctor Story Nepal - The U.S. Food and Drug Administration has approved etranacogene dezaparvovec (Hemgenix), the first gene therapy option for adults with hemophilia B who currently use factor IX prophylaxis therapy,
Hemophilia: Video, Anatomy, Definition & Function | Osmosis